Cathie Wood's ARK Innovation Stocks Performance Guide: Pacific Biosciences of Calif (PACB)
PACB has no dividends.
Table and Chart of PACB Performance
See what a $1,000 investment in PACB is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PACB Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $4.96 |
| End Date | May-16-2024 |
| End Price | $2.19 |
| # Prices | 121 |
| Min Date | Apr-30-2024 |
| Min Price | $1.65 |
| Max Date | Jun-30-2021 |
| Max Price | $34.97 |
| Total Return | -55.85% |
| Annualized Return | -7.79% |
| Current Value of $1,000 Purchase | $442 |
| Number Returns | 7,260 |
| Average Return | 87.77% |
| Number Profitable Returns | 4,154 |
| Percent Profitable Returns | 57.22% |
| Number Unprofitable Returns | 3,106 |
| Percent Unprofitable Returns | 42.78% |
| Profitable to Unprofitable Returns Ratio | 1.34 |
| PACB Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $584,204,000 |
| Beta | 1.981 | Price to Sales | 4.24 |
| Earnings per Share | $-1.1400 |
| PE Ratio | None |
| PE to Growth Ratio | -0.17 |
| Price to Book | 1.211 |
| PRICE DATA | |
| 52 Week High | $14.55 |
| 52 Week Low | $1.25 |
| Analyst Target Price | $4.67 |
| 50-Day Moving Average | $2.812 |
| 200-Day Moving Average | $7.0 |
| FINANCIAL DATA | |
| Revenue per Share | $0.769 |
| Revenue | $200,431,000 |
| Profit Margin | -148.1% |
| Return on Equity | -44.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PACB Compare Returns with S&P 500
PACB Trendline Chart
PACB Moving Average Chart
PACB Stock Return Map - See Patterns of Gains and Losses
PACB Stock Returns/Purchase Dates